How Hereditary Cancer screening works?
Agiomix Hereditary Cancer Panel uses Next Generation Sequencing to analyse mutations in the following genes: ATM, APC, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11 and TP53.
Agiomix uses clinically validated kits for Germline analysis (SNPs & INDELs) of DNA extracted from blood.
The Hereditary Cancer Panel uses specific bidirectional amplicon libraries for Next Generation Sequencing on the illumina MiSeq System:
- Panel size: 145 kb
- Coverage: Full exons plus 20bp padding regions
What is the information provided in the Report?
Agiomix provides a comprehensive clinical report reviewed by our Medical Board of Consultants and Genetic Experts. Pre and post-test consultation are also available to insure the complete understanding of the results.